Surgical Film Festival

Surgical Film Festival: Surgery for Fertility Preservation

This film session will demonstrate novel techniques for preserving fertility in patients with gynecologic and pelvic cancers. Topics covered will include fertility sparing surgery for cervical cancer, uterine transposition, and assisted reproductive techniques for women requiring pelvic radiation.

This film festival was organized by Vance Broach, Surgical Education Lead of the IGCS Education Committee.

Patient Perspectives Roundtable

Global Patient Perspectives Roundtable
Navigating Telehealth/Telemedicine & Embracing Shared Decision-Making

Recorded on Saturday, November 21, 2020

This Global Patient Perspectives Roundtable—focused on Telehealth/Telemedicine and Shared Decision-Making—is the first in a series of four roundtables sponsored by GSK. These topics are relevant to patient care and outcomes, options, and autonomy and are especially significant in the backdrop of COVID-19 and of global discussions of health equity. Participating in this active exchange of information across populations, specialties, and regions, attendees will enhance their understanding of these important topics and be more empowered to exercise their rights and options related to each.

Moderator

Daniela Luvero
Member, IGCS Council
Gynecologic Oncologist, University Campus Bio Medico of Rome
Italy

 

Panelists

Gwen Darien
Executive Vice President, Patient Advocacy & Engagement, National Patient Advocate Foundation & Patient Advocate Foundation, USA

 

Miriam Mutebi
Breast Surgical Oncologist & Assistant Professor of Surgery, Aga Khan University Hospital
Kenya

 

Karen Begaii-Wilson
Cervical Cancer Survivor & Advocate
Navajo Nation
USA

Noriko Fujiwara
Oncology & Research Nurse
IMSUT Hospital of the Institute of Medical Science, University of Tokyo
Japan

 

Graziela Zibetti Dal Molin
Medical Oncologist
Beneficência Portuguesa de São Paulo Hospital
Brazil

 

Kimlin Ashing
Professor & Founding Director, Center of Community Alliance for Research & Education, City of Hope National Medical Center
USA

About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will

  • facilitate first-hand assessment of patient community needs and concerns
  • provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
  • address current patient and wider community concerns through live responses to question posted online during the session
  • promote strategic conversations with health care and research communities around specific issues
  • assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath

Each 60- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.

Latin America Webinar 2020

IGCS is hosting a Spanish-language webinar in collaboration with our Latin American Strategic Alliance Partners.
The live event will be held in Spanish with English translation. The recording will be Spanish only.

Selected Topics in Gynecologic Oncology Webinar
Tópicos selectos en Ginecología Oncológica Seminario Web
Saturday, December 5, 2020 | Sábado, Diciembre 5, 2020

9:00 am—12:00 pm EST

Registration is free but required.

Register Here

 

Course Objectives

  • To understand the current status of surgical options in ovarian cancer.
  • To update the current indications of Neo-adjuvant chemotherapy in cervical cancer.

Moderators

Clemente Arab, MD
Instituto Oncológico FALP
Chile

Magaly Malca, MD
Hospital Edgardo Rebagliati Martins
Perú

Speakers

Ovarian Cancer

Pedro Ramirez, MD 
The University of Texas – MD Anderson Cancer Center
USA

What is new in surgical treatment of ovarian cancer

 

Reitan Ribeiro, MD
Erasto Gaertner Hospital
Brazil 

… What if TRUST trial has a positive result?

 

Alejandro Rauh-Hain, MD
The University of Texas – MD Anderson Cancer Center
USA

… What if TRUST trial has a negative result?

 

Cervix Cancer

Myriam Perrotta, MD 
Hospital Italiano de Buenos Aires
Argentina

Impact of the HPV vaccination on cervical cancer mortality

 

Juliana Rodriguez, MD
Instituto Nacional de Cancerología
Colombia

Neo-adjuvant chemotherapy in pregnant women with cervical cancer

 

Fabio Martinelli, MD 
Fondazione IRCCS Istituto Nazionale dei Tumori
Italy 

Neo-adjuvant chemotherapy in cervical cancer state-of-the-art

 


René Pareja, MD
Instituto Nacional de Cancerología-Bogota; Clínica de Oncología Astorga-Medellín
Colombia

Neo-adjuvant chemotherapy and fertility preservation in cervical cancer

 

Descargar Agenda (Espanol) Download Agenda (English)

 

Watch: WHO Cervical Cancer Elimination Launch Nov 17

The WHO is launching its Global Strategy to Accelerate the Elimination of Cervical Cancer on November 17, 2020. 

Main event (Part I):
14:30 to 16:00 CET (Geneva)

Webinar (Part II): New technical materials to support implementation
16:15 to 17:45 CET (Geneva)

Click here to visit the WHO website to learn about the program, watch the live stream and register for the webinar.

Congratulations to IGCS Global Curriculum Graduates!

Congratulations to three fellows from Maputo Central Hospital in Mozambique completing the IGCS Gynecologic Oncology Global Curriculum & Mentorship Program!

Veja esta mensagem em Portugues.

Dr. Dércia Changule
Maputo Central Hospital, Mozambique
Dr. Siro Daud
Maputo Central Hospital, Mozambique
Dr. Ricardina Rangeiro
Maputo Central Hospital, Mozambique

The Global Curriculum was established in 2017 under the leadership of then-President, Michael Quinn. It is a comprehensive two-year education and training program designed for regions around the world that do not currently have formal training in gynecologic oncology.

Congratulations to Drs. Changule, Daud, and Rangeiro on achieving this important milestone. They will be the first formally trained gynecologic oncologists in Mozambique.

To learn more about the program, please download the 2019 Annual Report.

Those who would like to learn more about how to contribute to the mentorship and training aspects of this program, please email mary.eiken@igcs.org.

Dr. Dércia Changule
Maputo Central Hospital, Mozambique
Fellowship Training Completed: 2020

“Thank you very much to the whole IGCS team. I am aware that with the program many Mozambican women will be benefited, (during the training, many Mozambican women with gynecological cancer received the appropriate treatment), it is our duty to continue treat them properly.

Special thanks to Drs.: Kathleen Schmeler, Ellen Baker, Mila Pontremoli Salcedo, Geórgia Fontes Cintra, Renato Moretti, Andre Lopes and Marcelo Vieira who were engaged to train us (I am sure that we can always count with you), you trained us with professionalism and goodwill, in a country that did not even have an oncologist gynaecologist. Thank you, amazing team!”

Dr. Siro Daud
Maputo Central Hospital, Mozambique
Fellowship Training Completed: 2020

“The IGCS GC Program changed the approach of diagnosis and treatment of gynecologic malignancies in Mozambique. Our training played a key role in this change. I am happy to be part of this program.”

Dr. Ricardina Rangeiro
Maputo Central Hospital, Mozambique
Fellowship Training Completed: 2020

“It was a great and unique opportunity to be part of this program. I will be forever grateful to the mentors and all the staff involved …Mozambique is now part of Gynecology Oncology team!!!”

We would like to sincerely thank their local mentors in Mozambique: Drs. Elvira Luis and Magda Ribeiro as well as our six volunteer international mentors: Drs. André Lopes (Instituto Brasileiro de Controle do Câncer e Instituto do Câncer do Estado de São Paulo), Georgia Fontes-Cintra (Hospital Sírio-Libanes), Kathleen Schmeler (The University of Texas MD Anderson Cancer Center), Marcelo Vieira (Hospital Israelita Albert Einstein), Mila Pontremoli Salcedo (Santa Casa de Misericórdia de Porto Alegre/Universidade Federal de Ciências da Saúde de Porto Alegre/ The University of Texas MD Anderson Cancer Center) e Renato Moretti (Hospital Israelita Albert Einstein).

Spotlight on IGCS Fellows & Mentors

The IGCS Member Spotlight is back, now with a focus on Fellows and International Mentors participating in the IGCS Global Curriculum & Mentorship Program.

Ricardina Rangeiro
Hospital Central de Maputo
Maputo, Mozambique
Fellow of the IGCS Global Curriculum & Mentorship Program

Where did you complete your training? Or tell us about your background in gyn oncology.
I’m doing my training in Mozambique that I started in 2018. 

Why did you decide to pursue a career in gyn oncology or what about it interested you?  
I’ve always been interested in oncology and during my residency, I’ve noticed that the patients arrived in advanced stages, so I thought what could I do to make a change. 

Tell us about your work in women’s cancer: daily activities and/or special projects.
I work in a ward that take care of women with gynecological cancer. Every day we do rounds, stage the patients with cancer, do biopsies. We also do colposcopies and leeps in the clinic of pre-invasive lesions. Twice a week we do surgeries. 

Tell us about the person or people who have inspired you the most in your career.
My mother, she is a pediatrician and the person responsible for my love of medicine.  

What is the most rewarding part of your career?
The most rewarding part of my career is being capable to treat and relieve the pain of our patients and being able to help these women. 

What is the most beneficial resource or equipment you have access to at your training site?
The most beneficial resource or equipment we have access to is the big volume of patients and radiotherapy. 

What is one of the biggest challenges in gyn cancer care in your region? What resources are lacking?
One of the biggest challenges in gyn cancer care in my region is that there isn’t enough trained medical staff. There is only 1 radiotherapy center for the entire country, and the pathology center with the best trained pathologists is only available in Maputo. 

How long have you been a member and how did you become involved with IGCS?
I’ve known IGCS when I started the program. 

Is there a story/example of a time you were especially proud of your involvement with IGCS?
I’m always proud of my involvement with IGCS. It’s been such an honor to be part of this program and being able to make a huge change in cancer care of gynecology patients. 

What does being a part of the IGCS Global Curriculum & Mentorship Program mean to you?
Being part of the IGCS Global Curriculum & Mentorship Program means I’m being trained by the best in this area, which is a unique experienceIt means a lot to have access to mentors and their guidance because we can get the tools we need to treat thpatients 

Do you have any hobbies or is there an interesting fact about your life that you’d like to share?
Apart from medicine, I like to run. It’s my moment, only mine, to recharge my battery. And of course, enjoy quality time with family and friends. 

What is a unique or fun fact about your country or community culture?
We are a resilient people; against all odds, we get up every day and get the job done with a smile on our faces 

Does your country/region have a traditional food or drink? Do you like it?
Yes, our prawns are one of the best in the worldZambezian chicken prepared with coconut milk, our matava and drinks we have maheu that is made with corn flour are also good. 

 

See more Member Spotlights.

Would you like to be featured in the Member Spotlight? We’d love to hear your story! Complete this form.

Fellows and Mentors in the IGCS Global Curriculum & Mentorship Program should complete this form which includes additional prompts about the program.

CEO Update: COVID-19 Survey Results

Dear Members and Friends,

In this CEO Update, I’d like to share with you the results from our recent COVID-19 survey, provide an update on IGCS 2020 abstracts and our upcoming Surgical Film Festival with AAGL, and remind readers of the International Journal of Gynecological Cancer to complete the 2020 readership survey.

COVID-19 Survey Results

We would like to thank our members for taking the time to complete our international survey of gynecologic cancer care providers to help us better understand the global impact of the COVID-19 pandemic on cancer care in the initial months of the pandemic. An executive summary of the results is now available.

Download COVID-19 Survey Results Executive Summary

We received responses from a total of 270 participants from 62 countries, with representation largely from North America, South America, and Asia. 83% were gynecologic oncologists and the rest included medical oncologists, radiation oncologists, pathologists, and nurses. The primary practice of 97% of participants is in clinical work and 91% work in an urban setting. 70% work in academic medical centers while 26% work in community hospitals.

From the survey responses, we learned that there is a definite and urgent need for the IGCS to comprehensively evaluate and understand the impact of the COVID-19 pandemic on gynecologic cancer practice and women’s cancer care. This understanding goes to the raison d’être of the Society in supporting its membership through education, advocacy, and political activism for women living with cancer all over the world. If you are interested in informational resources IGCS has compiled related to cancer care and COVID-19, please visit our COVID-19 page for resources, articles and recordings of educational tumor boards.

I would also like to thank Dr. Joseph Ng, IGCS Council Member and Chair of the Mentorship and Training Committee for his work in developing the survey questions and Dr. Li Min Lim for analyzing and compiling the executive summary.

The IGCS will be diving deeper and into some of the comments and responses you have provided. We intend to share what we find on these deep dives across our entire suite of information-distribution platforms including social media and in our society journal, the International Journal of Gynecological Cancer.

IGCS 2020 xDigital Annual Global Meeting

Abstract and Surgical Film Submission for the IGCS 2020 Annual Global Meeting closed on July 15, 2020 at 11:59 pm PDT. We are grateful to have received over 500 abstracts and surgical films.

Late Breaking Abstracts will be accepted from July 25-August 15. Please note that the late breaking submission site is reserved for high priority data that was not fully available at the time of original submission deadline on July 15. Other submissions will not be considered for acceptance.

There is still plenty of time to register for IGCS 2020. Learn more about the meeting which will be 100% digital. Session details will be released soon but until then, please view the program overview to see all the great sessions that will be offered.

IGCS/AAGL Surgical Film Festival

The next IGCS/AAGL Film Festival covering surgical complications will be held July 29, 2020 at 5:00 pm CDT. This online event is free but registration is required. View the program outline and speakers.

 

IJGC Readership Survey (July 2020)

The International Journal of Gynecological Cancer is conducting a readership survey to collect feedback from IGCS members and subscribers regarding journal content and educational offerings such as podcasts, video articles and different article types.

Please complete the IJGC survey here.

 

In closing, I’d like to thank the numerous volunteer leaders who allow IGCS to achieve our goals and better the care for women with gynecologic malignancies.

Sincerely,

Mary Eiken, MS
IGCS CEO

IGCS-AAGL Surgical Film Festival

IGCS in partnership with AAGL is providing a free online surgical film festival narrated by expert surgeons in the field of gynecologic oncology. Attendees can participate in live discussion while viewing the surgical films.

State-of-the-Art Surgical Film Festival: Complications
Wednesday, July 29, 2020

5:00 pm – 7:00 pm CDT

Ureteral & Bladder Complications (AAGL)
Bladder Injury and Repair & Post-operative Management
60 minutes

Moderator

Dr. Suketu Mansuria
University of Pittsburgh School of Medicine; Magee Women’s Hospital 
USA

 

Intra-Op Repair, Repair of Delayed Injury, and Post-operative Management

Dr. Ted Lee
University of Pittsburgh School of Medicine; Magee Women’s Hospital 
USA

 

Dr. Erin Carey
University of North Carolina
USA

Intra-Op Repair vs. Delayed Diagnoses, Reimplantation vs. Reanastamosis, Post-Op Management

Dr. Javier Magrina
Mayo Clinic
USA

 

Dr. Jim Robinson
MedStar Washington Hospital Center
USA

 

Bowel & Vascular Complications (IGCS)
60 minutes

Moderator

Dr. Vance Broach
Memorial Sloan-Kettering Cancer Center
USA

 

Vascular Injury & Repair, External Iliac Vessel

Dr. Mario Leitao
Memorial Sloan-Kettering Cancer Center
USA

 

Vascular Injury & Repair, Inferior Vena Cava

Dr. Jamie Bakkum Gamez
Mayo Clinic
USA

 

Managing Thermal Injury to Bowel

Dr. Jennifer Mueller
Memorial Sloan-Kettering Cancer Center
USA

 

Management of Anastomotic Leak

Dr. Bill Cliby
Mayo Clinic
USA

 

 

 

IGCS COVID-19 Survey Results

We would like to thank our members for taking the time to complete our international survey of gynecologic cancer care providers to help us better understand the global impact of the COVID-19 pandemic on cancer care in the initial months of the pandemic. An executive summary of the results is now available.

Download: IGCS Survey on the Impact of COVID-19 on Gynecologic Cancer Care Executive Summary July 2020

We received responses from a total of 270 participants from 62 countries, with representation largely from North America, South America, and Asia. 83% were gynecologic oncologists and the rest included medical oncologists, radiation oncologists, pathologists, and nurses. The primary practice of 97% of participants is in clinical work and 91% work in an urban setting. 70% work in academic medical centers while 26% work in community hospitals.

From the survey responses, we learned that there is a definite and urgent need for the IGCS to comprehensively evaluate and understand the impact of the COVID-19 pandemic on gynecologic cancer practice and women’s cancer care. This understanding goes to the raison d’être of the Society in supporting its membership through education, advocacy, and political activism for women living with cancer all over the world. If you are interested in informational resources IGCS has compiled related to cancer care and COVID-19, please visit our COVID-19 page for resources, articles and recordings of educational tumor boards.

I would also like to thank Dr. Joseph Ng, IGCS Council Member and Chair of the Mentorship and Training Committee for his work in developing the survey questions and Dr. Li Min Lim for analyzing and compiling the executive summary.

The IGCS will be diving deeper and into some of the comments and responses you have provided. We intend to share what we find on these deep dives across our entire suite of information-distribution platforms including social media and in our society journal, the International Journal of Gynecological Cancer.

Education Highlight: In the Know

This month’s Education Highlight is from In the Know (Ed’s List)

In the Know is prepared by Edward Pavlik, PhD, Professor and Director of Ovarian Screening Research Program, University of Kentucky on a monthly basis. Ed’s lists provide a compilation of abstracts related to the field of gynecologic oncology from multiple scholarly journals.

Here’s an example of one abstract from the June 2020 In the Know compilation:

Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. MP Salcedo, AK Sood, A Jhingran, PJ Eifel, AH Klopp, RB Iyer, BM Fellman, C Jimenez, KM Schmeler. Cancer, (2020) 126: 2607-2613. doi:10.1002/cncr.32807 https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.32807

Background  Advances in radiotherapy (RT) have led to improved oncologic outcomes for women with gynecologic cancers; however, the long‐term effects and survivorship implications need further evaluation. The purpose of this study was to determine the incidence of pelvic fractures and changes in bone mineral density (BMD) after pelvic RT.

Methods  Two hundred thirty‐nine women who had pelvic RT for cervical, endometrial, or vaginal cancer between 2008 and 2015 were prospectively studied. BMD scans and biomarkers of bone turnover were obtained at the baseline and 3 months, 1 year, and 2 years after RT. Imaging studies were assessed for pelvic fractures for up to 5 years. Patients with osteopenia, osteoporosis, or pelvic fractures at any point were referred to the endocrinology service for evaluation and treatment.

Results  The median age at diagnosis was 51 years; 132 patients (56%) were menopausal. The primary diagnoses were cervical (63.6%), endometrial (30.5%), and vaginal cancer (5.9%). Sixteen patients (7.8%; 95% confidence interval, 4.5%‐12.4%) had pelvic fractures with actuarial rates of 3.6%, 12.7%, and 15.7% at 1, 2, and 3 years, respectively. Fractures were associated with baseline osteoporosis ( < .001), higher baseline bone‐specific alkaline phosphatase ( < .001), and older age ( = .007). The proportion of patients with osteopenia/osteoporosis increased from 50% at the baseline to 58%, 59%, and 70% at 3 months, 1 year, and 2 years, respectively.

Conclusions  A high proportion of women had significant decreases in BMD after pelvic RT, with 7.8% diagnosed with a pelvic fracture. BMD screening and pharmacologic intervention should be strongly considered for these high‐risk women.

Stay “In the Know” and keep up with Ed’s List in the Members-Only IGCS Literature Library. Click here to login to the Member’s Education Portal and access the entire archive.